DATA INTO ACTION

CVD is a leading cause of premature death, health inequalities, economic inactivity and cost to health and social care.

​

CVD is highly preventable, through:

 

1. Lifestyle change

2. Treatment of high-risk conditions.

 

Large numbers of people with high blood pressure, high cholesterol, diabetes and kidney disease are not on recommended preventive treatments. These conditions often have no symptoms and can be difficult to manage well in high pressure GP consultations.

​

Developed with UCLPartners, Size of the Prize shows the scale of the challenge and the scale of the opportunity. For example, in England:

​

• A third of people with diagnosed hypertension are not treated to target, with huge variation between GP practices.

• Improving care so that 4 in 5 people were treated to target would prevent around 18,000 heart attacks and strokes every year, with major savings for the economy.

 

This is a realistic ambition, but to achieve it primary care teams need support to do things differently and get proactive - routinely identifying patients on suboptimal treatment, prioritising those at greatest risk, breaking down workload into manageable chunks, and optimising treatment at scale.

​

​CVDACTION has been designed for this purpose - with data that is highly actionable in real world primary care and implementation support to mobilise the wider workforce and transform pathways.

​

The GP Contract 2025-26

​The Quality and Outcomes Framework requires GP practices to achieve higher levels of blood pressure and cholesterol control, with significantly higher payments.

​

The Primary Care Network contract includes a new payment to use digital tools to risk stratify patients in accordance with need.

​

See how CVDACTION has been designed to  help GPs deliver the contract.